139 related articles for article (PubMed ID: 29590749)
1. Discovery of a Potent (4 R,5 S)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling.
Chen H; Volgraf M; Do S; Kolesnikov A; Shore DG; Verma VA; Villemure E; Wang L; Chen Y; Hu B; Lu AJ; Wu G; Xu X; Yuen PW; Zhang Y; Erickson SD; Dahl M; Brotherton-Pleiss C; Tay S; Ly JQ; Murray LJ; Chen J; Amm D; Lange W; Hackos DH; Reese RM; Shields SD; Lyssikatos JP; Safina BS; Estrada AA
J Med Chem; 2018 Apr; 61(8):3641-3659. PubMed ID: 29590749
[TBL] [Abstract][Full Text] [Related]
2. Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.
Schenkel LB; Olivieri PR; Boezio AA; Deak HL; Emkey R; Graceffa RF; Gunaydin H; Guzman-Perez A; Lee JH; Teffera Y; Wang W; Youngblood BD; Yu VL; Zhang M; Gavva NR; Lehto SG; Geuns-Meyer S
J Med Chem; 2016 Mar; 59(6):2794-809. PubMed ID: 26942860
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action via Cryogenic Electron Microscopy.
Terrett JA; Chen H; Shore DG; Villemure E; Larouche-Gauthier R; Déry M; Beaumier F; Constantineau-Forget L; Grand-Maître C; Lépissier L; Ciblat S; Sturino C; Chen Y; Hu B; Lu A; Wang Y; Cridland AP; Ward SI; Hackos DH; Reese RM; Shields SD; Chen J; Balestrini A; Riol-Blanco L; Lee WP; Liu J; Suto E; Wu X; Zhang J; Ly JQ; La H; Johnson K; Baumgardner M; Chou KJ; Rohou A; Rougé L; Safina BS; Magnuson S; Volgraf M
J Med Chem; 2021 Apr; 64(7):3843-3869. PubMed ID: 33749283
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential ankyrin 1 (TRPA1) antagonists: a patent review (2015-2019).
Chen H; Terrett JA
Expert Opin Ther Pat; 2020 Sep; 30(9):643-657. PubMed ID: 32686526
[TBL] [Abstract][Full Text] [Related]
5. TRPA1 ankyrin repeat six interacts with a small molecule inhibitor chemotype.
Tseng WC; Pryde DC; Yoger KE; Padilla KM; Antonio BM; Han S; Shanmugasundaram V; Gerlach AC
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):12301-12306. PubMed ID: 30429323
[TBL] [Abstract][Full Text] [Related]
6. α-Aryl pyrrolidine sulfonamides as TRPA1 antagonists.
Verma VA; Shore DGM; Chen H; Chen J; Do S; Hackos DH; Kolesnikov A; Lyssikatos JP; Tay S; Wang L; Estrada AA
Bioorg Med Chem Lett; 2016 Jan; 26(2):495-498. PubMed ID: 26706172
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and pharmacological evaluation of piperidin-4-yl amino aryl sulfonamides: novel, potent, selective, orally active, and brain penetrant 5-HT₆ receptor antagonists.
Nirogi R; Shinde A; Daulatabad A; Kambhampati R; Gudla P; Shaik M; Gampa M; Balasubramaniam S; Gangadasari P; Reballi V; Badange R; Bojja K; Subramanian R; Bhyrapuneni G; Muddana N; Jayarajan P
J Med Chem; 2012 Nov; 55(21):9255-69. PubMed ID: 23006002
[TBL] [Abstract][Full Text] [Related]
8. Potent and selective ET-A antagonists. 2. Discovery and evaluation of potent and water soluble N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivatives.
Morimoto H; Ohashi N; Shimadzu H; Kushiyama E; Kawanishi H; Hosaka T; Kawase Y; Yasuda K; Kikkawa K; Yamauchi-Kohno R; Yamada K
J Med Chem; 2001 Oct; 44(21):3369-77. PubMed ID: 11585442
[TBL] [Abstract][Full Text] [Related]
9. New water-soluble sulfonylphosphoramidic acid derivatives of the COX-2 selective inhibitor cimicoxib. A novel approach to sulfonamide prodrugs.
Almansa C; Bartrolí J; Belloc J; Cavalcanti FL; Ferrando R; Gómez LA; Ramis I; Carceller E; Merlos M; García-Rafanell J
J Med Chem; 2004 Oct; 47(22):5579-82. PubMed ID: 15481993
[TBL] [Abstract][Full Text] [Related]
10. Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3- a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNa
Focken T; Chowdhury S; Zenova A; Grimwood ME; Chabot C; Sheng T; Hemeon I; Decker SM; Wilson M; Bichler P; Jia Q; Sun S; Young C; Lin S; Goodchild SJ; Shuart NG; Chang E; Xie Z; Li B; Khakh K; Bankar G; Waldbrook M; Kwan R; Nelkenbrecher K; Karimi Tari P; Chahal N; Sojo L; Robinette CL; White AD; Chen CA; Zhang Y; Pang J; Chang JH; Hackos DH; Johnson JP; Cohen CJ; Ortwine DF; Sutherlin DP; Dehnhardt CM; Safina BS
J Med Chem; 2018 Jun; 61(11):4810-4831. PubMed ID: 29737846
[TBL] [Abstract][Full Text] [Related]
11. Discovery of heterocyclic sulfonamides as sphingosine 1-phosphate receptor 1 (S1P1) antagonists.
Hennessy EJ; Grewal G; Byth K; Kamhi VM; Li D; Lyne P; Oza V; Ronco L; Rooney MT; Saeh JC; Su Q
Bioorg Med Chem Lett; 2015; 25(10):2041-5. PubMed ID: 25890801
[TBL] [Abstract][Full Text] [Related]
12. An oral sphingosine 1-phosphate receptor 1 (S1P(1)) antagonist prodrug with efficacy in vivo: discovery, synthesis, and evaluation.
Angst D; Janser P; Quancard J; Buehlmayer P; Berst F; Oberer L; Beerli C; Streiff M; Pally C; Hersperger R; Bruns C; Bassilana F; Bollbuck B
J Med Chem; 2012 Nov; 55(22):9722-34. PubMed ID: 23067318
[TBL] [Abstract][Full Text] [Related]
13. Optimization of spirocyclic proline tryptophan hydroxylase-1 inhibitors.
Goldberg DR; De Lombaert S; Aiello R; Bourassa P; Barucci N; Zhang Q; Paralkar V; Stein AJ; Holt M; Valentine J; Zavadoski W
Bioorg Med Chem Lett; 2017 Feb; 27(3):413-419. PubMed ID: 28041831
[TBL] [Abstract][Full Text] [Related]
14. Reduction in lipophilicity improved the solubility, plasma-protein binding, and permeability of tertiary sulfonamide RORc inverse agonists.
Fauber BP; René O; de Leon Boenig G; Burton B; Deng Y; Eidenschenk C; Everett C; Gobbi A; Hymowitz SG; Johnson AR; La H; Liimatta M; Lockey P; Norman M; Ouyang W; Wang W; Wong H
Bioorg Med Chem Lett; 2014 Aug; 24(16):3891-7. PubMed ID: 25017032
[TBL] [Abstract][Full Text] [Related]
15. Transient Receptor Potential Ankyrin 1 and Substance P Mediate the Development of Gastric Mucosal Lesions in a Water Immersion Restraint Stress Rat Model.
Xu Y; Jia J; Xie C; Wu Y; Tu W
Digestion; 2018; 97(3):228-239. PubMed ID: 29428952
[TBL] [Abstract][Full Text] [Related]
16. Glutathione-S-transferase selective release of metformin from its sulfonamide prodrug.
Rautio J; Vernerová M; Aufderhaar I; Huttunen KM
Bioorg Med Chem Lett; 2014 Nov; 24(21):5034-6. PubMed ID: 25248681
[TBL] [Abstract][Full Text] [Related]
17. Sulfonamides as Selective Na
Graceffa RF; Boezio AA; Able J; Altmann S; Berry LM; Boezio C; Butler JR; Chu-Moyer M; Cooke M; DiMauro EF; Dineen TA; Feric Bojic E; Foti RS; Fremeau RT; Guzman-Perez A; Gao H; Gunaydin H; Huang H; Huang L; Ilch C; Jarosh M; Kornecook T; Kreiman CR; La DS; Ligutti J; Milgram BC; Lin MJ; Marx IE; Nguyen HN; Peterson EA; Rescourio G; Roberts J; Schenkel L; Shimanovich R; Sparling BA; Stellwagen J; Taborn K; Vaida KR; Wang J; Yeoman J; Yu V; Zhu D; Moyer BD; Weiss MM
J Med Chem; 2017 Jul; 60(14):5990-6017. PubMed ID: 28324649
[TBL] [Abstract][Full Text] [Related]
18. 2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models.
Walpole C; Ko SY; Brown M; Beattie D; Campbell E; Dickenson F; Ewan S; Hughes GA; Lemaire M; Lerpiniere J; Patel S; Urban L
J Med Chem; 1998 Aug; 41(17):3159-73. PubMed ID: 9703462
[TBL] [Abstract][Full Text] [Related]
19. Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors.
DiMauro EF; Altmann S; Berry LM; Bregman H; Chakka N; Chu-Moyer M; Bojic EF; Foti RS; Fremeau R; Gao H; Gunaydin H; Guzman-Perez A; Hall BE; Huang H; Jarosh M; Kornecook T; Lee J; Ligutti J; Liu D; Moyer BD; Ortuno D; Rose PE; Schenkel LB; Taborn K; Wang J; Wang Y; Yu V; Weiss MM
J Med Chem; 2016 Sep; 59(17):7818-39. PubMed ID: 27441383
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and efficacious gamma-secretase inhibitors (Part II).
Ye XM; Konradi AW; Smith J; Aubele DL; Garofalo AW; Marugg J; Neitzel ML; Semko CM; Sham HL; Sun M; Truong AP; Wu J; Zhang H; Goldbach E; Sauer JM; Brigham EF; Bova M; Basi GS
Bioorg Med Chem Lett; 2010 Jun; 20(12):3502-6. PubMed ID: 20529683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
